Successfully treating three patients with acute kidney injury secondary to COVID-19 by peritoneal dialysis: Case report and literature review

Al-Hwiesh, Abdullah K; Mohammed, Abdelgalil Moaz; Nokeety, Mahmoud M El; Alhwiesh, Amani; Al-Audah, Nadia; Esam, Syed; Abdul-Rahman, Ibrahiem Saeed

doi:10.1177/0896860820953050

Cited by 9 publications

(10 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All forms of RRTs have been employed. Peritoneal dialysis has been tried successfully and remains a valuable tool especially during periods of acute surge in the number of patients requiring RRT [ 26 , 27 ]. The modality of RRT is often selected based on patient characteristics and resource availability.…”

Section: Discussionmentioning

confidence: 99%

Incidence and Outcome of Acute Kidney Injury in Patients Hospitalized With Coronavirus Disease-19 at a Tertiary Care Medical Center in Saudi Arabia

Farooqui¹,

Almegren²,

Binrushud³

et al. 2021

Cureus

View full text Add to dashboard Cite

The systemic acute respiratory syndrome coronavirus (SARS-CoV-2) has been associated with acute kidney injury (AKI). We retrospectively studied the incidence and outcome of AKI in patients hospitalized with COVID-19 at King Abdulaziz Medical City (KAMC) Riyadh, Kingdom of Saudi Arabia. MethodsA retrospective cohort study was conducted after ethical approval from the institutional review board of King Abdullah International Medical Research Center (KAIMRC). Subjects were identified by Data Management Office of KAIMRC. The data were extracted from electronic medical records using a customized data collection sheet.The study included all adult patients (>18 years) who tested positive for COVID-19 by polymerase chain reaction and were admitted at KAMC from March 2020 until the end of September 2020. Patients with a history of end-stage kidney diseases and patients where adequate data were not available to establish diagnosis of AKI were excluded.Patient demographics, comorbid conditions, medications, use of mechanical ventilation, and 30-day mortality were recorded.

show abstract

Section: Discussionmentioning

confidence: 99%

Incidence and Outcome of Acute Kidney Injury in Patients Hospitalized With Coronavirus Disease-19 at a Tertiary Care Medical Center in Saudi Arabia

Farooqui¹,

Almegren²,

Binrushud³

et al. 2021

Cureus

View full text Add to dashboard Cite

show abstract

“…Since heart failure dramatically worsens and requires urgent care, it is important to confirm heart failure associated with COVID-19 and begin individualized treatment, including diuretics or dialysis [ 7 ]. Although several cases of urgent peritoneal dialysis for acute kidney injury and heart failure induced by COVID-19 have been reported, there have been only a few case reports of heart failure caused by COVID-19 in maintenance PD patients to date [ 8 , 9 ]. Jiang et al recently reported an observational study in PD patients during the COVID-19 outbreak.…”

Section: Discussionmentioning

confidence: 99%

Two episodes of acute dyspnea that were induced by COVID-19 in a peritoneal dialysis patient

et al. 2021

View full text Add to dashboard Cite

Dialysis patients have an increased risk of coronavirus disease 2019 (COVID-19)-related mortality. Acute heart failure is a frequent, lethal complication of COVID-19, and it is a risk factor for mortality in hemodialysis patients. Therefore, it is crucial to rapidly distinguish heart failure from COVID-19 pneumonia. Here, we report a case of two episodes of acute dyspnea that were induced by COVID-19 in a peritoneal dialysis (PD) patient. The first episode of acute dyspnea was an exacerbation of heart failure caused by COVID-19 when the patient had a volume overload status due to a peritoneal dialysis catheter malfunction. Heart failure induced by a catheter malfunction was due to omental wrapping, and it was treated with ultrafiltration by hemodialysis and mini-laparotomy. The patient's acute dyspnea was immediately resolved. The second episode of acute dyspnea was caused by COVID-19 pneumonia, which occurred 1 week after the first episode. This case suggests the importance of identifying heart failure and beginning adequate treatment, in COVID-19 patients with PD.

show abstract

“…Coronavirus Disease 2019 (COVID-19) has widely spread in the worldwide scale with serious disaster [1].Acute kidney injury (AKI) has a higher rate of morbidity and mortality in common complication for critical illnesses and counted about 5-7 % of hospitalized patients in world [2].-Several studies have evaluated the development of AKI is more strongly related to worse outcomes and mortality rates of COVID-19, described incidence of AKI that ranges widely from 0.5 to 36.6 % in COVID-19 patients [3].Early detection and precise treatments of AKI can implement better preventive strategies and prevent deterioration of renal function and renal failure, effectively contain progression of the COVID-19 hospitalized patients [4]. Among them, neutrophil gelatinase-associated lipocalin (NGAL) has been recognized as one of the promising biomarkers candidate for detection of AKI.…”

Section: Introductionmentioning

confidence: 99%

Development of a europium nanoparticles lateral flow immunoassay for NGAL detection in urine and diagnosis of acute kidney injury

et al. 2022

View full text Add to dashboard Cite

Background AKI is related to severe adverse outcomes and mortality with Coronavirus Disease 2019 (COVID-19) patients, that early diagnosed and intervened is imperative. Neutrophil gelatinase-associated lipocalin (NGAL) is one of the most promising biomarkers for detection of acute kidney injury (AKI), but current detection methods are inadequacy, so more rapid, convenient and accuracy methods are needed to detect NGAL for early diagnosis of AKI. Herein, we established a rapid, reliable and accuracy lateral flow immunoassay (LFIA) based on europium nanoparticles (EU-NPS) for the detection of NGAL in human urine specimens. Methods A double-antibody sandwich immunofluorescent assay using europium doped nanoparticles was employed and the NGAL monoclonal antibodies (MAbs) conjugate as labels were generated by optimizing electric fusion parameters. Eighty-three urine samples were used to evaluate the clinical application efficiency of this method. Results The quantitative detection range of NGAL in AKI was 1-3000 ng/mL, and the detection sensitization was 0.36 ng/mL. The coefficient of variation (CV) of intra-assay and inter-assay were 2.57-4.98 % and 4.11-7.83 %, respectively. Meanwhile, the correlation coefficient between europium nanoparticles-based lateral fluorescence immunoassays (EU-NPS-LFIA) and ARCHITECT analyzer was significant (R2 = 0.9829, n = 83, p < 0.01). Conclusions Thus, a faster and easier operation quantitative assay of NGAL for AKI has been established, which is very important and meaningful to diagnose the early AKI, suggesting that the assay can provide an early warning of final outcome of disease.

show abstract

Successfully treating three patients with acute kidney injury secondary to COVID-19 by peritoneal dialysis: Case report and literature review

Cited by 9 publications

References 5 publications

Incidence and Outcome of Acute Kidney Injury in Patients Hospitalized With Coronavirus Disease-19 at a Tertiary Care Medical Center in Saudi Arabia

Incidence and Outcome of Acute Kidney Injury in Patients Hospitalized With Coronavirus Disease-19 at a Tertiary Care Medical Center in Saudi Arabia

Two episodes of acute dyspnea that were induced by COVID-19 in a peritoneal dialysis patient

Development of a europium nanoparticles lateral flow immunoassay for NGAL detection in urine and diagnosis of acute kidney injury

Contact Info

Product

Resources

About